AGP Picks
View all

Somaliland Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Health Watch.

Press releases published on October 16, 2026

Propanc Biopharma’s Lead Asset PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells
Outlook for the Medical Device Flexible Printed Circuits Market Improves Driven by Increasing Global Demand
Medical Device Contract Design and Engineering Market Size, Share, Trends, Growth and Forecast to 2030
Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology
Once-Weekly TransCon® CNP (Navepegritide) Receives Positive CHMP Opinion for the Treatment of Achondroplasia in Children
Global Medical Device Contract Micro-Molding Market Expected to Exceed $2.7 Billion by 2030
Global Medical Balloon Manufacturing Market Size, Share, Trends, Growth and Forecast to 2030
Inspire Named Finalist in Two Categories at the 6th Annual Anthem Awards
GrowthHit Pledges 1% of Profits to Pediatric Cancer Research Following Founder's Daughter's Cancer Battle
Lubricious Medical Device Coatings Market Size, Trends, Share and Growth Forecast 2030
Beat Cancer Foundation Challenges Americans to Ask Bigger Questions About Cancer and Take a More Active Role
Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026
Nanox AI Ltd. Enters into Distribution Agreement with Technologic s.r.l., an Affiliate of Tecnologie Avanzate, to Commercialize Nanox.AI Bone Solution in Italy
hear.com Receives 2026 Global Recognition Award for Hearing Care Innovation
twiist™ Automated Insulin Delivery System is Now Cleared for Adults with Type 2 Diabetes
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
OXB Appoints Joachim Kreuzburg as Independent Non-Executive Director
Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types
Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026
Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Somaliland Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.